Spots Global Cancer Trial Database for human papilloma virus
Every month we try and update this database with for human papilloma virus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence | NCT06255938 | Human Papilloma... Sexual Assault Sex Abuse | smears | 15 Years - | Centre Hospitalier Universitaire Saint Pierre | |
Avelumab for People With Recurrent Respiratory Papillomatosis | NCT02859454 | Recurrent Respi... Juvenile Laryng... Laryngeal Papil... Respiratory Pap... Human Papilloma... | Avelumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV) Clinical Trial | NCT06367699 | Human Papilloma... | Usual Care ECA-HPV App wit... ECA-HPV App wit... ECA-HPV App wit... ECA-HPV App wit... | 9 Years - 12 Years | Tufts Medical Center | |
Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement | NCT04645602 | Human Papilloma... Recurrent Respi... | Lenvatinib Pembrolizumab | 18 Years - | Massachusetts General Hospital | |
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
Carrageenan for the Prevention of Oral HPV Infection | NCT05746988 | Human Papilloma... | Mouthwash gargl... | 18 Years - 45 Years | McGill University | |
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | NCT03947775 | Anal Intraepith... Anal Cancer Human Papilloma... | 9-valent HPV va... | 18 Years - | University Health Network, Toronto | |
The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV | NCT06205511 | Human Immunodef... Human Papilloma... | Oral HPV Sample | 18 Years - | Vivent Health | |
Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN) | NCT04771546 | Human Papilloma... | Colpofix | 30 Years - 50 Years | Uriach Consumer Healthcare | |
Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening | NCT05756192 | Human Papilloma... Cervical Dyspla... | Educational vid... | 21 Years - 65 Years | George Washington University | |
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men | NCT00428285 | Anus Neoplasms HIV Infections | Argon Plasma Co... | 18 Years - 65 Years | Centre hospitalier de l'Université de Montréal (CHUM) | |
A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3 | NCT04208269 | Human Papilloma... | postcard campai... Health Informat... | 11 Years - 18 Years | University of Florida | |
Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis | NCT04950101 | Human Papilloma... | anal sampling | 18 Years - | Universitair Ziekenhuis Brussel | |
Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis | NCT04950101 | Human Papilloma... | anal sampling | 18 Years - | Universitair Ziekenhuis Brussel | |
Patient Self-sampling of HPV to Screen for Cervical Cancer | NCT05600283 | Human Papilloma... | Swab kit (COBAS... Clinician-colle... | 25 Years - 65 Years | Mayo Clinic | |
SMS Messaging for Invitation in the Cervical Cancer Screening Programme | NCT05362669 | Cervical Cancer Human Papilloma... | SMS invitation Phone call invi... | 35 Years - 65 Years | Institut Català d'Oncologia | |
Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination | NCT05175482 | Human Papilloma... Health Behavior | Virtual Educati... | 18 Years - | Marmara University | |
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV | NCT04002154 | Human Papilloma... Human Papilloma... Cervix Lesion | Papilocare vagi... | 30 Years - 65 Years | Procare Health Iberia S.L. | |
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS? | NCT03903952 | ASC-US Human Papilloma... | Vitamin B12 and... | 30 Years - 65 Years | Sanliurfa Mehmet Akif Inan Education and Research Hospital | |
Acceptance of Human Papillomavirus Vaccination in Postpartum Women | NCT00730704 | Human Papilloma... HPV Post Partum | 18 Years - 26 Years | Columbia University | ||
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV | NCT01663558 | Anal Dysplasia Human Papilloma... HIV | imiquimod ablative | 18 Years - | United States Naval Medical Center, San Diego | |
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | NCT04679675 | Uterine Cervica... Uterine Neoplas... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Uterine Cervica... Uterine Disease... Cervical Cancer Cervical Dyspla... Human Papilloma... HPV-Related Cer... HPV Infection HPV-Related Mal... | Usual Care Education Direct Mail Opt-in | 30 Years - 64 Years | Kaiser Permanente | |
Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases. | NCT04180228 | Systemic Lupus ... Idiopathic Juve... Human Papilloma... | self-administre... | 11 Years - 19 Years | Hospices Civils de Lyon | |
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. | NCT04232917 | Human Papilloma... | 2LPAPI® Placebo | 25 Years - 45 Years | Labo'Life | |
PreTeenVax Evaluation | NCT03186430 | Human Papilloma... | Comprehensive V... | 11 Years - 12 Years | Emory University | |
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine | NCT04611022 | Human Papilloma... | HPV Educational... | 18 Years - | University of Colorado, Denver | |
Anal Cancer Risk In Women | NCT05835947 | Anal Cancer Human Papilloma... Anal Intraepith... Genital Neoplas... Genital Cancer | Dual Pathology | 25 Years - 100 Years | Imperial College London | |
Acceptance of Human Papillomavirus Vaccination in Postpartum Women | NCT00730704 | Human Papilloma... HPV Post Partum | 18 Years - 26 Years | Columbia University | ||
Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
Human Papilloma Virus DNA Self-Test | NCT00266266 | Papilloma Virus... | 18 Years - | University of Louisville | ||
Clinical Validation of Cervical Cancer Screening Methods | NCT04783649 | Cervical Cancer Cervical Dyspla... Human Papilloma... | Papanicolaou cy... Local cytologic... Validated HPV D... Local HPV test Colposcopy | 25 Years - 65 Years | N.N. Petrov National Medical Research Center of Oncology | |
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia | NCT05640700 | Human Papilloma... Vaginal Flora I... Cancer Cervix U... Cervical Dyspla... | 25 Years - 70 Years | Hadassah Medical Organization | ||
ERADICATING CERVICAL CANCER IN KENYA | NCT04774887 | Human Papilloma... HIV Infections | HPV vaccine, Me... | 9 Years - 60 Years | Indiana University | |
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand | NCT03302858 | HSIL, High Grad... Anal Cancer HPV-Related Squ... Human Papilloma... Human Papilloma... Ain III | BARRX™ Anorecta... | 18 Years - 75 Years | Laser Surgery Care | |
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | NCT01530997 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin Limited surgica... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination | NCT03350698 | Papillomavirus ... | Gardasil-9 | 27 Years - 69 Years | Eastern Virginia Medical School | |
Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV | NCT05566106 | Human Papilloma... | 18 Years - | Fondation Hôpital Saint-Joseph | ||
Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN) | NCT04771546 | Human Papilloma... | Colpofix | 30 Years - 50 Years | Uriach Consumer Healthcare | |
ERADICATING CERVICAL CANCER IN KENYA | NCT04774887 | Human Papilloma... HIV Infections | HPV vaccine, Me... | 9 Years - 60 Years | Indiana University | |
Human Papillomatosis Genotyping of Children in Thailand | NCT01304966 | Recurrent Laryn... Human Papilloma... | biopsy | - 18 Years | Queen Sirikit National Institute of Child Health | |
Engaging Clinical Champions to Improve HPV Vaccination | NCT05736718 | Human Papilloma... | Champion Announ... Traditional Ann... | 9 Years - 12 Years | UNC Lineberger Comprehensive Cancer Center | |
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men | NCT04154358 | Transgenderism Cervical Cancer Human Papilloma... | HPV testing | 21 Years - | Augusta University | |
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study | NCT05065840 | Human Papilloma... Human Papilloma... | CDC 4 Pillars P... | 18 Years - 45 Years | Emory University | |
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old, An Exploratory Immunogenicity Study | NCT05329961 | Human Papilloma... | Gardasil9 | 4 Years - 8 Years | Boston Medical Center | |
Cultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by Lay Navigators | NCT03139669 | Human Papilloma... | Viba collection... | 30 Years - 65 Years | University of Virginia | |
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection | NCT03239223 | HSIL HSIL of Cervix High-Grade Squa... High-grade Cerv... Human Papilloma... Cervical Cancer Cervical Intrae... Cervical Neopla... Cervical Dyspla... CIN | ABI-1968 | 25 Years - 50 Years | Antiva Biosciences | |
Promise Women Project | NCT05862844 | Human Papilloma... Cervical Cancer | Promise women p... | 18 Years - | University of Kentucky | |
Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL | NCT01957878 | Genital Infecti... HUMAN PAPILLOMA... | ProCervix Placebo | 25 Years - 50 Years | Genticel | |
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts | NCT05291845 | Warts Human Papilloma... | Candida antigen... Bivalent HPV va... | 9 Years - | Zagazig University | |
CASUS: Validation for Detection of Precursor Lesions | NCT04530201 | Cervical Cancer Cervical Intrae... Human Papilloma... HPV-Related Cer... Urine | Colli-Pee Small... | 25 Years - 64 Years | Universiteit Antwerpen | |
Hashtag HPV: HPV Vaccine Twitter Education Program | NCT05204030 | Human Papilloma... Vaccine-Prevent... | HPV Twitter Edu... HPV Twitter Edu... | 18 Years - | University of Arkansas, Fayetteville | |
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device | NCT03429582 | Cervical Intrae... | Standard C02 Cr... Single Tip Ther... Multiple Tip Th... | 18 Years - | The Cleveland Clinic | |
Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients | NCT03525210 | Human Papilloma... Hiv Organ Transplan... | 9-valent HPV va... | 18 Years - 55 Years | Universitaire Ziekenhuizen KU Leuven | |
Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City | NCT02382900 | Human Papilloma... | quadrivalent hu... | 10 Years - 11 Years | Universidad Nacional Autonoma de Mexico | |
Marketability of a Technology-based Intervention to Increase HPV Vaccination | NCT03497936 | Human Papilloma... | Women's Stories | 18 Years - 26 Years | Real Prevention, LLC | |
Research in Ethno-Medicine and Education (REMED) | NCT05907187 | Cervical Cancer Human Papilloma... HPV Human Papilloma... | Cervical Cancer... | 18 Years - | University of Miami | |
Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views | NCT06154239 | Chlamydia Gonorrhea Bacterial Vagin... Human Papilloma... | DAYE Diagnostic... Vaginal self-sw... Clinician vagin... | 25 Years - 65 Years | Anne's Day Ltd | |
Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive Patients | NCT03742375 | Human Immunodef... | HPV genotyping | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. | NCT04232917 | Human Papilloma... | 2LPAPI® Placebo | 25 Years - 45 Years | Labo'Life | |
Development of a Self-collection Device for Cervical Cancer Screening | NCT05669911 | Human Papilloma... Human Papilloma... Human Papilloma... | Teal Health Sel... | 25 Years - 65 Years | Teal Health, Inc. | |
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers | NCT05108870 | Human Papilloma... HPV HPV Positive Or... Head and Neck C... | HB-201 HB-202 Carboplatin Paclitaxel Transoral Robot... | 18 Years - | University of Chicago | |
Hashtag HPV: HPV Vaccine Twitter Education Program | NCT05204030 | Human Papilloma... Vaccine-Prevent... | HPV Twitter Edu... HPV Twitter Edu... | 18 Years - | University of Arkansas, Fayetteville | |
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities | NCT00501189 | Papillomavirus ... | human papilloma... | 18 Years - 26 Years | Eisenhower Army Medical Center | |
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts | NCT05291845 | Warts Human Papilloma... | Candida antigen... Bivalent HPV va... | 9 Years - | Zagazig University | |
Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test | NCT05431699 | Human Papilloma... | ScreenFire HPV ... careHPV test Colposcopy and ... Gas-based cryot... Thermal ablatio... | 30 Years - 59 Years | The Cleveland Clinic | |
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis | NCT04724980 | Recurrent Respi... Papillomavirus ... Papillomavirida... | PRGN-2012 | 18 Years - | Precigen, Inc | |
Infrared Bioeffect System for the Treatment of Cutaneous Warts | NCT03734003 | Cutaneous Warts Human Papilloma... | liquid nitrogen controllable in... | 18 Years - 70 Years | First Hospital of China Medical University | |
Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology | NCT04369339 | Human Papilloma... | Colposcopy | 18 Years - 65 Years | Bezmialem Vakif University | |
Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial | NCT05996783 | Cervix Cancer Cervical Intrae... Human Papilloma... HPV-Related Cer... | Colli-Pee Small... Evalyn Brush | 31 Years - 64 Years | Universiteit Antwerpen | |
Intralesional HPV Vaccine for Condylomata | NCT05087849 | Human Papilloma... Warts Warts, Genital Condyloma Condylomata Acu... | nonavalent huma... | 18 Years - | University of California, San Francisco | |
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study | NCT05065840 | Human Papilloma... Human Papilloma... | CDC 4 Pillars P... | 18 Years - 45 Years | Emory University | |
Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity | NCT03895905 | Human Papilloma... Cervical Neopla... | colposcopy and ... | 20 Years - 65 Years | Kanuni Sultan Suleyman Training and Research Hospital | |
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis | NCT04724980 | Recurrent Respi... Papillomavirus ... Papillomavirida... | PRGN-2012 | 18 Years - | Precigen, Inc | |
Circulating Biomarkers in Oropharyngeal Cancers | NCT05904327 | Oropharynx Squa... Oropharynx Canc... Tonsillar Cance... Base of the Ton... | - | Region Örebro County | ||
HPV Infections, Cancer of the Vulva and Therapeutical Success | NCT03082950 | HPV Human Papilloma... | polymerase chai... | - | University of Luebeck | |
Patient Self-sampling of HPV to Screen for Cervical Cancer | NCT05600283 | Human Papilloma... | Swab kit (COBAS... Clinician-colle... | 25 Years - 65 Years | Mayo Clinic | |
Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls | NCT00956553 | HPV Infections | Cervarix Gardasil | 13 Years - 15 Years | Public Health England | |
Immune Response Evaluation to Curative Conventional Therapy | NCT03053661 | Head and Neck S... | 18 Years - | University of Ulm |